Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN

  1. Shannon L. Stroschein1,
  2. Shirin Bonni2,
  3. Jeffrey L. Wrana2, and
  4. Kunxin Luo1,3
  1. 1Life Sciences Division, Lawrence Berkeley National Laboratory and Dept. of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA; 2Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada

Abstract

Smad proteins mediate transforming growth factor-β (TGF-β) signaling to regulate cell growth and differentiation. SnoN is an important negative regulator of TGF-β signaling that functions to maintain the repressed state of TGF-β target genes in the absence of ligand. On TGF-β stimulation, Smad3 and Smad2 translocate into the nucleus and induce a rapid degradation of SnoN, allowing activation of TGF-β target genes. We show that Smad2- or Smad3-induced degradation of SnoN requires the ubiquitin-dependent proteasome and can be mediated by the anaphase-promoting complex (APC) and the UbcH5 family of ubiquitin-conjugating enzymes. Smad3 and to a lesser extent, Smad2, interact with both the APC and SnoN, resulting in the recruitment of the APC to SnoN and subsequent ubiquitination of SnoN in a destruction box (D box)-dependent manner. In addition to the D box, efficient ubiquitination and degradation of SnoN also requires the Smad3 binding site in SnoN as well as key lysine residues necessary for ubiquitin attachment. Mutation of either the Smad3 binding site or lysine residues results in stabilization of SnoN and in enhanced antagonism of TGF-β signaling. Our studies elucidate an important mechanism and pathway for the degradation of SnoN and more importantly, reveal a novel role of the APC in the regulation of TGF-β signaling.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL kluo{at}lbl.gov; FAX (510) 486-6488.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.912901.

    • Received May 18, 2001.
    • Accepted August 16, 2001.
| Table of Contents

Life Science Alliance